Braskem is trading at BRL 4.10, down 5.09%, after creditors reportedly demanded a $3 billion capital injection from controlling shareholders Petrobras and IG4 Capital to support debt restructuring.
- The restructuring involves approximately $11 billion in debt.
- Creditors reportedly do not plan to provide additional funding without a firm commitment, intensifying dilution and restructuring concerns.
- The broader market is weaker, but the creditor demand is the clearest catalyst.